Search research articles
Contact Us
Filters
Showing results (41-50 of 168) with videos related to
Page
of 17
Sort By:
BMC Cancer
|
April 5, 2012
Prognostic impact of mRNA levels of osteopontin splice variants in soft tissue sarcoma patients
Antje Hahnel, Henri Wichmann, Thomas Greither, et al.
Journal of Clinical Medicine
|
May 30, 2019
Expression of PD-1 and CTLA-4 Are Negative Prognostic Markers in Renal Cell Carcinoma
Andreas Kahlmeyer, Christine G Stöhr, Arndt Hartmann, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
August 28, 2014
Targeting of EGFR and HER2 with therapeutic antibodies and siRNA: a comparative study in glioblastoma cells
Henri Wichmann, Antje Güttler, Matthias Bache, et al.
Journal of Clinical Medicine
|
January 11, 2024
Clean Intermittent Catheterization in Children under 12 Years Does Not Have a Negative Impact on Long-Term Graft Survival following Pediatric Kidney Transplantation
Marios Marcou, Matthias Galiano, Anja Tzschoppe, et al.
International Journal of Oncology
|
September 18, 2004
siRNA-mediated down-regulation of survivin inhibits bladder cancer cell growth
Shuangli Ning, Susanne Fuessel, Matthias Kotzsch, et al.
BMC Cancer
|
October 8, 2011
A novel splice variant of the stem cell marker LGR5/GPR49 is correlated with the risk of tumor-related death in soft-tissue sarcoma patients
Swetlana Rot, Helge Taubert, Matthias Bache, et al.
Journal of Clinical Medicine
|
November 25, 2023
Risk Factor Analysis for Long-Term Graft Survival Following Pediatric Kidney Transplantation: The Importance of Pretransplantation Time on Dialysis and Donor/Recipient Age Difference
Marios Marcou, Matthias Galiano, Anja Tzschoppe, et al.
Urologie (Heidelberg, Germany)
|
August 1, 2023
[Individualized precision medicine]
Bernd Wullich, Helge Taubert, Peter J Goebell, et al.
Cancer Gene Therapy
|
January 24, 2004
Knockdown of survivin expression by small interfering RNA reduces the clonogenic survival of human sarcoma cell lines independently of p53
Matthias Kappler, Matthias Bache, Frank Bartel, et al.
International Journal of Molecular Sciences
|
November 1, 2014
Betulinic acid derivatives NVX-207 and B10 for treatment of glioblastoma--an in vitro study of cytotoxicity and radiosensitization
Matthias Bache, Stephan Bernhardt, Sarina Passin, et al.
Page
of 17
Search research articles
Search
Showing results (41-50 of 168) with videos related to
Sort By:
Page
of 17
BMC Cancer
|
April 5, 2012
Prognostic impact of mRNA levels of osteopontin splice variants in soft tissue sarcoma patients
Antje Hahnel, Henri Wichmann, Thomas Greither, et al.
Journal of Clinical Medicine
|
May 30, 2019
Expression of PD-1 and CTLA-4 Are Negative Prognostic Markers in Renal Cell Carcinoma
Andreas Kahlmeyer, Christine G Stöhr, Arndt Hartmann, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
August 28, 2014
Targeting of EGFR and HER2 with therapeutic antibodies and siRNA: a comparative study in glioblastoma cells
Henri Wichmann, Antje Güttler, Matthias Bache, et al.
Journal of Clinical Medicine
|
January 11, 2024
Clean Intermittent Catheterization in Children under 12 Years Does Not Have a Negative Impact on Long-Term Graft Survival following Pediatric Kidney Transplantation
Marios Marcou, Matthias Galiano, Anja Tzschoppe, et al.
International Journal of Oncology
|
September 18, 2004
siRNA-mediated down-regulation of survivin inhibits bladder cancer cell growth
Shuangli Ning, Susanne Fuessel, Matthias Kotzsch, et al.
BMC Cancer
|
October 8, 2011
A novel splice variant of the stem cell marker LGR5/GPR49 is correlated with the risk of tumor-related death in soft-tissue sarcoma patients
Swetlana Rot, Helge Taubert, Matthias Bache, et al.
Journal of Clinical Medicine
|
November 25, 2023
Risk Factor Analysis for Long-Term Graft Survival Following Pediatric Kidney Transplantation: The Importance of Pretransplantation Time on Dialysis and Donor/Recipient Age Difference
Marios Marcou, Matthias Galiano, Anja Tzschoppe, et al.
Urologie (Heidelberg, Germany)
|
August 1, 2023
[Individualized precision medicine]
Bernd Wullich, Helge Taubert, Peter J Goebell, et al.
Cancer Gene Therapy
|
January 24, 2004
Knockdown of survivin expression by small interfering RNA reduces the clonogenic survival of human sarcoma cell lines independently of p53
Matthias Kappler, Matthias Bache, Frank Bartel, et al.
International Journal of Molecular Sciences
|
November 1, 2014
Betulinic acid derivatives NVX-207 and B10 for treatment of glioblastoma--an in vitro study of cytotoxicity and radiosensitization
Matthias Bache, Stephan Bernhardt, Sarina Passin, et al.
Page
of 17